Covalon Technologies (OTCMKTS:CVALF) Issues Earnings Results

Covalon Technologies (OTCMKTS:CVALF) released its quarterly earnings results on Tuesday. The company reported $0.01 earnings per share for the quarter, Zacks reports. Covalon Technologies had a negative return on equity of 4.40% and a negative net margin of 2.94%.

Covalon Technologies Price Performance

OTCMKTS:CVALF opened at $2.30 on Wednesday. Covalon Technologies has a 1-year low of $0.74 and a 1-year high of $3.08. The firm has a 50 day simple moving average of $2.51 and a 200-day simple moving average of $2.19. The firm has a market cap of $63.02 million, a PE ratio of -76.64 and a beta of -0.27.

About Covalon Technologies

Covalon Technologies Ltd. engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally. The company’s platform technologies comprise collagen matrix platform that is used to manufacture a family of products to treat chronic and infected wounds, including diabetic ulcers, pressure ulcers, venous ulcers, donor and graft sites, traumatic wounds healing by secondary intention, dehisced surgical wounds, and first and second degree burns; and antimicrobial silicone adhesive platform, which is used for family of pre and post-surgical, and vascular access products that are designed to kill bacteria or yeast that comes into contact with the antimicrobial silicone providing broad-spectrum antimicrobial activity.